Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan El Ghazzi

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Bulletin Du Cancer|March 27, 2023
[Rare tumors: Angiosarcoma]Nathan El-Ghazzi, Jacques-Olivier Bay
Frontiers in Immunology|October 20, 2025
Gene expression silencing therapy in tumors, focus on gastrointestinal and genitourinary tumorsNathan El-Ghazzi, Antoine Italiano, Eurydice Angeli
Journal of Hematology & Oncology|September 1, 2024
New strategies in soft tissue sarcoma treatmentMariella Spalato-Ceruso, Nathan El Ghazzi, Antoine Italiano
Bulletin Du Cancer|December 18, 2021
[Bispecific antibodies in onco-hematology: Applications and perspectives]Sabrina Barrière, Nathan El-Ghazzi, Manon Garcia, et al.
Oncotargets and Therapy|June 8, 2023
Targeted Treatment of Advanced Endometrial Cancer: Focus on PembrolizumabNathan El-Ghazzi, Xavier Durando, Alexia Giro, et al.
Molecular Cancer Therapeutics|October 30, 2023
Adoptive T Cell Therapy in Solid Tumors: State-of-the Art, Current Challenges, and Upcoming ImprovementsAurore Dougé, Nathan El Ghazzi, Richard Lemal, et al.
Bulletin Du Cancer|December 21, 2022
[CAR-T cells development in solid tumors]Nathan El Ghazzi, Antoine Italiano, Jacques-Olivier Bay, et al.
Platelets|April 3, 2025
Immune-induced thrombocytopenia by pembrolizumab: case report and review of literatureNathan El-Ghazzi, Anna Monier, Antoine Italiano, et al.
Journal of Hematology & Oncology|October 24, 2024
Predictive value of tumor microenvironment on pathologic response to neoadjuvant chemotherapy in patients with undifferentiated pleomorphic sarcomasJean Philippe Guegan, Nathan El Ghazzi, Julien Vibert, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Bulletin Du Cancer|March 27, 2023
[Rare tumors: Angiosarcoma]Nathan El-Ghazzi, Jacques-Olivier Bay
Frontiers in Immunology|October 20, 2025
Gene expression silencing therapy in tumors, focus on gastrointestinal and genitourinary tumorsNathan El-Ghazzi, Antoine Italiano, Eurydice Angeli
Journal of Hematology & Oncology|September 1, 2024
New strategies in soft tissue sarcoma treatmentMariella Spalato-Ceruso, Nathan El Ghazzi, Antoine Italiano
Bulletin Du Cancer|December 18, 2021
[Bispecific antibodies in onco-hematology: Applications and perspectives]Sabrina Barrière, Nathan El-Ghazzi, Manon Garcia, et al.
Oncotargets and Therapy|June 8, 2023
Targeted Treatment of Advanced Endometrial Cancer: Focus on PembrolizumabNathan El-Ghazzi, Xavier Durando, Alexia Giro, et al.
Molecular Cancer Therapeutics|October 30, 2023
Adoptive T Cell Therapy in Solid Tumors: State-of-the Art, Current Challenges, and Upcoming ImprovementsAurore Dougé, Nathan El Ghazzi, Richard Lemal, et al.
Bulletin Du Cancer|December 21, 2022
[CAR-T cells development in solid tumors]Nathan El Ghazzi, Antoine Italiano, Jacques-Olivier Bay, et al.
Platelets|April 3, 2025
Immune-induced thrombocytopenia by pembrolizumab: case report and review of literatureNathan El-Ghazzi, Anna Monier, Antoine Italiano, et al.
Journal of Hematology & Oncology|October 24, 2024
Predictive value of tumor microenvironment on pathologic response to neoadjuvant chemotherapy in patients with undifferentiated pleomorphic sarcomasJean Philippe Guegan, Nathan El Ghazzi, Julien Vibert, et al.
Pageof 1